128 related articles for article (PubMed ID: 28826697)
21. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
22. Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients.
De Crevoisier R; Bourhis J; Domenge C; Wibault P; Koscielny S; Lusinchi A; Mamelle G; Janot F; Julieron M; Leridant AM; Marandas P; Armand JP; Schwaab G; Luboinski B; Eschwege F
J Clin Oncol; 1998 Nov; 16(11):3556-62. PubMed ID: 9817275
[TBL] [Abstract][Full Text] [Related]
23. Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers.
Watkins JM; Shirai KS; Wahlquist AE; Stuart RK; Chaudhary UB; Garrett-Mayer E; Day TA; Gillespie MB; Sharma AK
Head Neck; 2009 Apr; 31(4):493-502. PubMed ID: 19156831
[TBL] [Abstract][Full Text] [Related]
24. Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies.
Kramer NM; Horwitz EM; Cheng J; Ridge JA; Feigenberg SJ; Cohen RB; Nicolaou N; Sherman EJ; Babb JS; Damsker JA; Langer CJ
Head Neck; 2005 May; 27(5):406-14. PubMed ID: 15719391
[TBL] [Abstract][Full Text] [Related]
25. Reirradiation using robotic image-guided stereotactic radiotherapy of recurrent head and neck cancer.
Yamazaki H; Ogita M; Himei K; Nakamura S; Suzuki G; Yoshida K; Kotsuma T; Yoshioka Y
J Radiat Res; 2016 Jun; 57(3):288-93. PubMed ID: 26983982
[TBL] [Abstract][Full Text] [Related]
26. Salvage stereotactic reirradiation with or without cetuximab for locally recurrent head-and-neck cancer: a feasibility study.
Comet B; Kramar A; Faivre-Pierret M; Dewas S; Coche-Dequeant B; Degardin M; Lefebvre JL; Lacornerie T; Lartigau EF
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):203-9. PubMed ID: 22331006
[TBL] [Abstract][Full Text] [Related]
27. [Intensity-modulated radiation therapy and stereotactic body radiation therapy for head and neck tumors: evidence-based medicine].
Lapierre A; Martin F; Lapeyre M
Cancer Radiother; 2014 Oct; 18(5-6):468-72. PubMed ID: 25155467
[TBL] [Abstract][Full Text] [Related]
28. Reirradiation of recurrent node-positive non-small cell lung cancer after previous stereotactic radiotherapy for stage I disease : A multi-institutional treatment recommendation.
Nieder C; De Ruysscher D; Gaspar LE; Guckenberger M; Mehta MP; Cheung P; Sahgal A
Strahlenther Onkol; 2017 Jul; 193(7):515-524. PubMed ID: 28424839
[TBL] [Abstract][Full Text] [Related]
29. [Treatment for recurrent head and neck carcinomas].
Tsukuda M
Gan To Kagaku Ryoho; 1998 Feb; 25(3):303-8. PubMed ID: 9492820
[TBL] [Abstract][Full Text] [Related]
30. Evidence based and new developments in re-irradiation for recurrent or second primary head and neck cancers.
Mouttet-Audouard R; Gras L; Comet B; Lartigau E
Curr Opin Otolaryngol Head Neck Surg; 2012 Apr; 20(2):137-41. PubMed ID: 22249172
[TBL] [Abstract][Full Text] [Related]
31. Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer.
Lartigau EF; Tresch E; Thariat J; Graff P; Coche-Dequeant B; Benezery K; Schiappacasse L; Degardin M; Bondiau PY; Peiffert D; Lefebvre JL; Lacornerie T; Kramar A
Radiother Oncol; 2013 Nov; 109(2):281-5. PubMed ID: 24262821
[TBL] [Abstract][Full Text] [Related]
32. Reirradiation: A complex situation.
Chargari C; Escande A; Dupuis P; Thariat J
Cancer Radiother; 2022 Oct; 26(6-7):911-915. PubMed ID: 35987812
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of nuclear factor-kappaB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinoma.
Van Waes C; Chang AA; Lebowitz PF; Druzgal CH; Chen Z; Elsayed YA; Sunwoo JB; Rudy SF; Morris JC; Mitchell JB; Camphausen K; Gius D; Adams J; Sausville EA; Conley BA
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1400-12. PubMed ID: 16005577
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors in patients with recurrent head and neck cancer treated with reirradiation.
Krstevska V; Tolevska C; Zafirova-Ivanova B; Stojkovski I; Crvenkova S
J BUON; 2008; 13(3):369-76. PubMed ID: 18979552
[TBL] [Abstract][Full Text] [Related]
35. What is the role of reirradiation in the management of locoregionally relapsed non small-cell lung cancer?
Nicosia L; Di Muzio J; Agolli L; Alongi F; Mazzola R; Valeriani M; Badellino S; Osti MF; Ricardi U
Lung Cancer; 2020 Aug; 146():263-275. PubMed ID: 32593916
[TBL] [Abstract][Full Text] [Related]
36. Reirradiation in squamous cell head and neck cancer: recent developments and future directions.
Langendijk JA; Bourhis J
Curr Opin Oncol; 2007 May; 19(3):202-9. PubMed ID: 17414637
[TBL] [Abstract][Full Text] [Related]
37. Postoperative reirradiation for mucosal head and neck squamous cell carcinomas.
Iseli TA; Iseli CE; Rosenthal EL; Caudell JJ; Spencer SA; Magnuson JS; Smith AN; Carroll WR
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1158-64. PubMed ID: 19917931
[TBL] [Abstract][Full Text] [Related]
38. Reirradiation of Skull Base Tumors With Advanced Highly Conformal Techniques.
Ho JC; Phan J
Curr Oncol Rep; 2017 Oct; 19(12):82. PubMed ID: 29080990
[TBL] [Abstract][Full Text] [Related]
39. A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell carcinoma of the head and neck.
Vargo JA; Ferris RL; Ohr J; Clump DA; Davis KS; Duvvuri U; Kim S; Johnson JT; Bauman JE; Gibson MK; Branstetter BF; Heron DE
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):480-8. PubMed ID: 25680594
[TBL] [Abstract][Full Text] [Related]
40. Stereotactic radiotherapy for reirradiation of head and neck cancer: Dosimetric details matter.
West N; Kelly C; Kovarik J; Iqbal MS
Head Neck; 2022 Jan; 44(1):287-288. PubMed ID: 34766399
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
